Prospects for control of herpesvirus-related diseases: a review.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002353:Carrier State; D006564:Herpesviridae / Q000276:immunology; D006566:Herpesviridae Infections / Q000151:congenital / Q000628:therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007136:Immunoglobulins / Q000627:therapeutic use; D007167:Immunotherapy; D007231:Infant, Newborn; D014740:Vidarabine / Q000627:therapeutic use; D014765:Viral Vaccines / Q000302:isolation & purification / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D007136:Immunoglobulins; D014765:Viral Vaccines; D014740:Vidarabine; D007065:Idoxuridine